Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

(2020) Leah W. Roberts et al.   Nature Communications

Molecular epidemiological analysis and risk factors for acquisition of carbapenemase-producing Enterobacter cloacae complex in a Japanese university hospital

(2019) Nobuyuki Tetsuka et al.   Antimicrobial Resistance and Infection Control

Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae

(2019) Kayoko Hayakawa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo

(2018) Kotaro Aoki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?

(2018) Despoina Koulenti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan

(2017) N. Yamamoto et al.   JOURNAL OF HOSPITAL INFECTION

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

(2017) Latania K. Logan et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

(2017) Belén Gutiérrez-Gutiérrez et al.   LANCET INFECTIOUS DISEASES

A prolonged outbreak of KPC-3-producing Enterobacter cloacae and Klebsiella pneumoniae driven by multiple mechanisms of resistance transmission at a large academic burn center

(2016) Hajime Kanamori et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia

(2016) Pranita D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms

(2016) Kalyan D. Chavda et al.   mBio

Comparison of Test Methods for Detecting Metallo-β-Lactamase-Producing Gram-Negative Bacteria

(2015) Tatsuya Hattori et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

MLST reveals potentially high-risk international clones of Enterobacter cloacae*

(2014) R. Izdebski et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Frequency of IMP-6 among Clinical Isolates of Metallo-β-Lactamase-Producing Escherichia coli in Japan

(2012) Hisakazu Yano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae

(2012) K. M. Wilkinson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing

(2012) E. S. Snitkin et al.   Science Translational Medicine

Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid

(2011) A. J. Mathers et al.   mBio

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL